Comments on the ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. A report of the task force of the clinical practice guidelines committee of the Spanish Society of Cardiology;Comentarios a la guia de practica clinica de la ESC sobre diagnostico y tratamiento de la insuficiencia cardiaca aguda y cronica 2012. Un informe del Grupo de Trabajo del Comite de Guias de Practica Clinica de la Sociedad Espanola de Cardiologia

Revista Espanola de Cardiologia

Volumn 65, Issue 10, 2012, Pages 874-878

  Comin, Josep ^a,b   Anguita, Manuel ^a,b   Crespo, Marisa ^a,b   Delgado, Juan ^a,b   Gonzalez Costello, Jose ^a,b   Hernandez Madrid, Antonio ^a,b   Manito, Nicolas ^a,b   Perez De La Sota, Enrique ^a,b   Segovia, Javier ^a,b   Segura, Carmen ^a,b   Alonso Gomez, Angel M ^a,b   Fernandez Lozano, Ignacio ^a,b   Fernandez Ortiz, Antonio ^a,b   Gomez De Diego, Jose J ^a,b   Pan, Manuel ^a,b   Worner, Fernando ^a,b   Alonso Pulpon, Luis ^a,b   Bover, Ramon ^a,b   Castro, Alfonso ^a,b   Diaz Molina, Beatriz ^a,b   Gomez Bueno, Manuel ^a,b   Gonzalez Juanatey, Jose R ^a,b   Lage, Ernesto ^a,b   Lopez Granados, Amador ^a,b   Lupon, Josep ^a,b   Martinez Dolz, Luis ^a,b   Munoz, Roberto ^a,b   Pascual, Domingo ^a,b   Ridocci, Francisco ^a,b   Roig, Eulalia ^a,b   Varela, Alfonso ^a,b   Vazquez De Prada, Jose A ^a,b   more..

^a Sociedad Espanola de Cardiologia ^*  (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART FAILURE; CHRONIC DISEASE; HUMAN; MEDICAL SOCIETY; PRACTICE GUIDELINE; REVIEW;

EID: 84866942834     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2012.07.013     Document Type: Article

References (28)

1. M. Anguita, A. Fernandez-Ortiz, F. Worner, A. Alonso, A. Cequier, and J. Comin La Sociedad Espanola de Cardiologia y las guias de practica clinica de la SEC: hacia una nueva orientacion Rev Esp Cardiol. 64 2011 795 796
2. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012 Jun 26.[Epub ahead of print].
3. K. Dickstein, A. Cohen-Solal, G. Filippatos, J.J. McMurray, P. Ponikowski, and P.A. Poole-Wilson ESC Committee for Practice Guidelines (CPG) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in c ollaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM) Eur Heart J. 29 2008 2388 2442
4. K. Swedberg, M. Komajda, M. Bohm, J.S. Borer, I. Ford, and A. Dubost-Brama Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebocontrolled study Lancet. 376 2010 875 885
5. M. Bohm, K. Swedberg, M. Komajda, J.S. Borer, I. Ford, and A. Dubost-Brama Heart rate as a risk factor in chronic heart failure (SHIFT): the association between heart rate and outcomes in a randomised placebo-controlled trial Lancet. 376 2010 886 894
6. K. Swedberg, M. Komajda, M. Bohm, J. Borer, M. Robertson, and L. Tavazzi Effects on Outcomes of Heart Rate Reduction by Ivabradine in Patients With Congestive Heart Failure: Is There an Influence of Beta-Blocker Dose?.: Findings From the SHIFT (Systolic Heart failure treatment with the I(f) inhibitor ivabradine Trial) Study J Am Coll Cardiol. 22. 2012 Feb [Epub ahead of print]
7. M. Bohm, J. Borer, I. Ford, J.R. Gonzalez-Juanatey, M. Komajda, and J. Lopez-Sendon Heart rate at baseline influences the effect of ivabradine on cardiovascular outcomes in chronic heart failure: analysis from the SHIFT study Clin Res Cardiol. 2012 May 11 [Epub ahead of print]
8. F. Zannad, J.J. McMurray, H. Krum, D.J. Van Veldhuisen, K. Swedberg, and H. Shi Eplerenone in patients with systolic heart failure and mild symptoms N Engl J Med. 364 2011 11 21
9. J. Butler, J.A. Ezekowitz, S.P. Collins, M.M. Givertz, J.R. Teerlink, and M.N. Walsh Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction Heart Failure Society of America Guidelines Committee J Card Fail. 18 2012 265 281
10. A. Kadish, A. Dyer, J.P. Daubert, R. Quigg, N.A. Estes, and K.P. Anderson Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy N Engl J Med. 350 2004 2151 2158
11. G.H. Bardy, K.L. Lee, D.B. Mark, J.E. Poole, D.L. Packer, and R. Boineau Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med. 352 2005 225 237
12. D.A. Theuns, T. Smith, M.G. Hunink, G.H. Bardy, and L. Jordaens Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta analysis Europace. 12 2010 1564 1570
13. C. Linde, W.T. Abraham, M.R. Gold, S.M. St John, S. Ghio, and C. Daubert Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms J Am Coll Cardiol. 52 2008 1834 1843
14. A.J. Moss, W.J. Hall, D.S. Cannom, H. Klein, M.W. Brown, and J.P. Daubert Cardiacresynchronization therapy for the prevention of heart failure events N Engl J Med. 361 2009 1329 1338
15. A.S. Tang, G.A. Wells, M. Talajic, M.O. Arnold, R. Sheldon, and S. Connolly Cardiacresynchronization therapy for mild-to-moderate heart failure N Engl J Med. 363 2010 2385 2395
16. W.G. Stevenson, A.F. Hernandez, P.E. Carson, J.C. Fang, S.D. Katz, and J.A. Spertus Heart Failure Society of America Guideline Committee Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee J Card Fail. 18 2012 94 106
17. I. Sipahi, T.P. Carrigan, D.Y. Rowland, B.S. Stambler, and J.C. Fang Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials Arch Intern Med. 171 2011 1454 1462
18. S. Stavrakis, R. Lazzara, and U. Thadani The benefit of cardiac resynchronization therapy and QRS duration: a meta-analysis J Cardiovasc Electrophysiol. 23 2012 163 168
19. E.J. Velazquez, K.L. Lee, M.A. Deja, A. Jain, G. Sopko, and A. Marchenko Coronary-artery bypass surgery in patients with left ventricular dysfunction N Engl J Med. 364 2011 1607 1616
20. M.R. Patel, G.J. Dehmer, HirshfeldJ.W. Smith, P.K. Spertus, and J.A. ACCF/SCAI/STS/AATS/AHA/ASNC2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography J Am Coll Cardiol. 53 2009 530 533
21. A. Vahanian, O. Alfieri, F. Andreotti, M.J. Antunes, G. Baron-Esquivias, and H. Baumgartner Guidelines on the Management of Valvular Heart Disease (Version 2012) The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J. 2012 ehs109 10.1093/eurheartj/
22. G. Buckberg, C.L. Athanasuleas, A.S. Wechsler, F. Beyersdorf, J.V. Conte, and J.E. Strobeck The STICH trial unravelled Eur J Heart Fail. 12 2010 1024 1027
23. V. Dor, F. Civaia, C. Alexandrescu, M. Sabatier, and F. Montiglio Favorable effects of left ventricular reconstruction in patients excluded from the Surgical Treatment for Ischemic Heart Failure (STICH) trial J Thorac Cardiovasc Surg. 141 2011 905 916
24. N.R. Banner, R.S. Bonser, A.L. Clark, S. Clark, P.J. Cowburn, and R. Gardner UK guidelines for referral and assessment of adults for heart transplantation Heart. 97 2011 1520 1527
25. J.K. Kirklin, D.C. Naftel, R.L. Kormos, L.W. Stevenson, F.D. Pagani, and M.A. Miller The fourth INTERMACS annual report: 4,000 implants and counting J Heart Lung Transplant. 31 2012 117 126
26. R.C. Starling, Y. Naka, A.J. Boyle, G. Gonzalez-Stawinski, R. John, and U. Jorde Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: A prospective study using the INTERMACS (interagency registry for mechanically assisted circulatory support) J Am Coll Cardiol. 57 2011 1890 1898
27. V. Jeevanantham, M. Butler, A. Saad, A. Abdel-Latif, E.K. Zuba-Surma, and B. Dawn Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis Circulation. 2012 June 22 [Epub ahead of print]
28. S.D. Anker, J. Comin-Colet, G. Filippatos, R. Willenheimer, K. Dickstein, and H. Drexler Ferric carboxymaltose in patients with heart failure and iron deficiency N Engl J Med. 361 2009 2436 2448